aLFA - SARS-CoV-2 Ag SALIVA, SARS-CoV-2 Ag NP, SARS-CoV-2 NAbs

Lateral flow assays (LFAs) are rapid and inexpensive diagnostic devices that can be used to test for a target substance (analyte) in a sample.
Some of the advantages to the LFA format are that these assays have a long shelf life, do not require refrigerated storage, and a result can be obtained in a short time without additional processing, external equipment, or extensive training.
The simplicity of this diagnostic is especially important for point-of-care or field-based diagnostic.

LFA Antigen SARS-CoV-2 is an In vitro rapid chromatographic test for the qualitative detection of SARS-CoV-2 Nucleocapsid protein (antigen) in saliva specimens directly collected from individuals who meet COVID-19 clinical and/or epidemiological criteria.

LFA Antigen SARS-CoV-2 is an In vitro rapid chromatographic test for the qualitative detection of SARS-CoV-2 Nucleocapsid protein (antigen) in nasopharyngeal swab specimens directly collected from individuals who meet COVID-19 clinical and/or epidemiological criteria.

LFA Neutralizing Antibodies SARS-CoV-2 is an In vitro rapid chromatographic test for the qualitative detection of SARS-CoV-2 neutralizing antibodies in human biological specimens (whole blood, plasma, serum).

Our products Other Products

MOLECULAR MOUSE SARS-CoV-2 ACE-RBD LFA NEUTRALIZING ANTIBODIES

Back to Virtual Stand